Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design

Berkan Sahin

Open source

DOI
10.1016/j.ejphar.2026.179270
Published
2026-10
Container
European Journal of Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179270,
  title = {Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design},
  author = {Berkan Sahin},
  year = {2026},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2026.179270},
  url = {https://doi.org/10.1016/j.ejphar.2026.179270}
}

RIS

TY  - JOUR
TI  - Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design
AU  - Berkan Sahin
PY  - 2026
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2026.179270
UR  - https://doi.org/10.1016/j.ejphar.2026.179270
ER  - 

APA

Sahin, B. (2026). Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.179270

Source records